ChemotherapyFDA-approvedFirst-line
Gemcitabine + nab-paclitaxel
How it works
Combination of two chemotherapy agents: gemcitabine and nab-paclitaxel. Gemcitabine interferes with DNA replication, causing cancer cells to die, while nab-paclitaxel blocks cell division.
Cancer types
Pancreatic Cancer— All patients
Efficacy
Gemcitabine plus nab-paclitaxel has been shown to improve overall survival in patients with metastatic pancreatic cancer, compared to gemcitabine alone.
Side effects
Moderate
Side effects can be significant and may require dose adjustments or supportive medication, but the treatment is usually continued.
Evidence from research
| Study | Cancer type | Stage | Efficacy | |
|---|---|---|---|---|
| Combination Therapy for Resectable Pancreatic Cancer Before Surgery | Pancreatic Cancer | phase-2 | — | Source → |
| Comparing Chemotherapy Options for Advanced Pancreatic Cancer | Pancreatic Cancer | meta-analysis | — | Source → |
This information is provided for general education only and is not medical advice. Always consult a qualified healthcare professional before making treatment decisions.